Naveglitazar Uses, Dosage, Side Effects and more
Naveglitazar has been used in trials studying the treatment of Diabetes Mellitus, Non-Insulin-Dependent.
| Trade Name | Naveglitazar |
| Generic | Naveglitazar |
| Naveglitazar Other Names | Naveglitazar |
| Type | |
| Formula | C25H26O6 |
| Weight | Average: 422.477 Monoisotopic: 422.172938557 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
